Drug Approval Package
-
ADVAIR DISKUS (Fluticasone Propionate and
Salmeterol Xinafoate) Inhalation Powder
Company: Glaxo Wellcome Inc.
Application No.: 21-077
Approval Date: 8/24/2000
-
Approval Letter(s) (PDF)
-
Printed Labeling (PDF)
-
Chemistry Review(s) (PDF)
-
Environmental Assessment (PDF)
-
Statistical Review(s) (PDF)
-
Correspondence (PDF)
Date created: February 03, 2003
Note: Documents in PDF format require the Adobe Acrobat Reader®.
-